Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 17, Issue 13, pp. 4232-4244
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 1, 2010
- Revision received February 28, 2011
- Accepted April 13, 2011
- Published first May 3, 2011.
Article Versions
- Previous version (May 3, 2011 - 13:09).
- Previous version (June 28, 2011 - 09:34).
- You are viewing the most recent version of this article.
Copyright & Usage
©2011 American Association for Cancer Research.
Author Information
- David J. Andorsky1,
- Reiko E. Yamada1,
- Jonathan Said2,
- Geraldine S. Pinkus3,
- David J. Betting1, and
- John M. Timmerman1
- Authors' Affiliations: 1Division of Hematology & Oncology, Department of Medicine, and 2Department of Pathology & Laboratory Medicine, University of California, Los Angeles, Los Angeles, California; and 3Department of Pathology, Harvard Medical School, Boston, Massachusetts
- Corresponding Author:
John M. Timmerman, Division of Hematology & Oncology, Center for Health Sciences, Room 42-121,10833 LeConte Avenue, University of California, Los Angeles Medical Center, Los Angeles, CA 90095. Phone: 310-794-4820; Fax: 310-206-5511; E-mail: jtimmerman{at}mednet.ucla.edu
July 2011
Volume 17, Issue 13
Volume 17, Issue 13
Programmed Death Ligand 1 Is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells
Jump to section
Advertisement